PRPO
Precipio, Inc.
Next earnings Aug 11, 2026
Last earnings -0.9% on 2026-02-27
$25.26
▲ +4.04%$25.26▲ +132.43%
over 1Y
L $10.87H $32.37
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+4.0%
1W+12.7%
1M+12.4%
3M-0.6%
YTD+6.0%
1Y+132.4%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 7 analysts
Buy
A genuine turnaround — revenue nearly tripled in 4 years and losses all but erased — but a going-concern flag and $2.65M cash cap the call.
Revenue $24.2M · FY2025
Precipio is a rare micro-cap where the operating story is actually improving on every line. Revenue has compounded from $8.70M (FY2021) to $24.2M (FY2025), up 30.5% in the latest year, and the diagnostics model is finally scaling: gross profit grew 41.6% (faster than revenue) to $10.7M, lifting gross margin to 44.2%. The bottom line went from a -$4.29M net loss in FY2024 to just -$363K in FY2025 — a 91.5% improvement — with operating income at -$1.20M and, critically, operating cash flow positive at $685K against only $326K of capex. The balance sheet is clean for a company this size: total debt is a trivial $77K (long-term $47K + current $30K), equity is $14.6M, and liabilities/equity is 0.46x. On valuation, a $45.1M market cap against $24.2M revenue is 1.9x sales — undemanding for ~30% growth if profitability holds. The MD&A's 'self-funded R&D' framing (the CLIA labs double as a validation engine at minimal incremental cost) is a credible explanation for how a sub-scale player reached positive OCF.
Is PRPO a buy? The one-page verdict, explained →
The options angle
model · matches our verdictCovered call~60d expiry
- Long 100 shares @ ~25.26
- Short call 27 @ ~1.07 est
debit $2,419max +$281max −$2,418BE 24.19
HOLD means own it, don't chase it — harvesting premium against the position matches the verdict.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
Financials · annual, by fiscal year
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $8.70M | $9.82M | $15.4M | $18.6M | $24.2M |
| Gross profit | $2.39M | $2.51M | $6.02M | $7.56M | $10.7M |
| Operating income | -$9.61M | -$12.8M | -$7.62M | -$4.22M | -$1.20M |
| Net income | — | — | — | -$4.29M | -$363K |
| Diluted EPS | -$0.40 | -$10.73 | -$4.51 | -$2.93 | -$0.23 |
| Net margin | — | — | — | -23.1% | -1.5% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$42.6M
EV / EBITDA990.1
EV / Sales1.8
EV / FCF118.6
P / FCF125.8
PEG (trailing)—
Earnings yield-0.8%
FCF yield0.8%
Quality & risk
ROIC (est.)-6.5%
Free cash flow$359K
Total debt$77.0K
Net cash$2.57M
Altman Z-Score-1.66 distress
Piotroski F-Score7/9
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+18.6%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRecent disclosure tone has been improving.
- 8-K Shareholder vote2026-06-15
Annual meeting vote results certified; routine governance, no business change
- 10-Q Quarterly report2026-05-14
Q1'26 10-Q: growth trajectory continues off record FY2025 base
- 8-K Reg FD disclosure2026-05-06
Reg FD disclosure w/ exhibit (investor/PR update); no financial results
- DEF 14A Proxy statement2026-04-28
DEF 14A proxy for annual meeting; routine director/comp votes
- 10-K Annual report2026-03-30
FY2025: revenue +30% to $24.2M, loss cut 91% to -$363K; going-concern doubt
- 8-K Earnings results2026-02-27
Q4/FY2025 results: revenue +30.5% to $24.2M, loss nearly erased
- 8-K Officer / director change2025-12-29
Officer/director change reported; leadership transition, impact unclear
- 10-Q Quarterly report2025-11-14
Q3'25 10-Q: revenue growth and margin gains continue toward breakeven
- 8-K Reg FD disclosure2025-11-06
Reg FD disclosure w/ exhibit; investor communication, no financials
Recent filings
all on EDGAR ↗8-KPeriod ending 2026-06-152026-06-15open ↗4Period ending 2026-05-212026-05-26open ↗4Period ending 2026-05-192026-05-21open ↗144Filing2026-05-19open ↗10-QPeriod ending 2026-03-312026-05-14open ↗8-KPeriod ending 2026-05-062026-05-06open ↗ARSPeriod ending 2025-12-312026-04-28open ↗DEFA14AFiling2026-04-28open ↗DEF 14APeriod ending 2026-06-152026-04-28open ↗4Period ending 2026-04-152026-04-17open ↗4Period ending 2026-04-152026-04-17open ↗4Period ending 2026-04-152026-04-17open ↗
Frequently asked
- Is Precipio, Inc. (PRPO) a buy?
- PRPO currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. A genuine turnaround — revenue nearly tripled in 4 years and losses all but erased — but a going-concern flag and $2.65M cash cap the call.
- What is Precipio, Inc.'s quality score?
- PRPO scores 63.76857604557848/100 (grade C+) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001043961, latest 10-Q filed 2026-05-14) · EODHD · Proprietary analysis · as of 7/4/2026, 9:26:07 AM.
About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 5:26 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.